231 related articles for article (PubMed ID: 1376702)
1. Anti-CD3 immunotoxin prevents low-dose STZ/interferon-induced autoimmune diabetes in mouse.
Vallera DA; Carroll SF; Brief S; Blazar BR
Diabetes; 1992 Apr; 41(4):457-64. PubMed ID: 1376702
[TBL] [Abstract][Full Text] [Related]
2. Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.
Herold KC; Bluestone JA; Montag AG; Parihar A; Wiegner A; Gress RE; Hirsch R
Diabetes; 1992 Mar; 41(3):385-91. PubMed ID: 1532369
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and efficacy of anti-T-cell ricin toxin A chain immunotoxins in a murine model of established graft-versus-host disease induced across the major histocompatibility barrier.
Vallera DA; Carroll SF; Snover DC; Carlson GJ; Blazar BR
Blood; 1991 Jan; 77(1):182-94. PubMed ID: 1984794
[TBL] [Abstract][Full Text] [Related]
4. In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment.
Blazar BR; Hirsch R; Gress RE; Carroll SF; Vallera DA
J Immunol; 1991 Sep; 147(5):1492-503. PubMed ID: 1831826
[TBL] [Abstract][Full Text] [Related]
5. Diabetes induced with low doses of streptozotocin is mediated by V beta 8.2+ T-cells.
Herold KC; Bloch TN; Vezys V; Sun Q
Diabetes; 1995 Mar; 44(3):354-9. PubMed ID: 7883124
[TBL] [Abstract][Full Text] [Related]
6. Induction of tolerance to autoimmune diabetes with islet antigens.
Herold KC; Montag AG; Buckingham F
J Exp Med; 1992 Oct; 176(4):1107-14. PubMed ID: 1402656
[TBL] [Abstract][Full Text] [Related]
7. Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
Baumann EE; Buckingham F; Herold KC
Diabetes; 1995 Aug; 44(8):871-7. PubMed ID: 7621990
[TBL] [Abstract][Full Text] [Related]
8. Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice.
Harlan DM; Barnett MA; Abe R; Pechhold K; Patterson NB; Gray GS; June CH
Diabetes; 1995 Jul; 44(7):816-23. PubMed ID: 7540575
[TBL] [Abstract][Full Text] [Related]
9. In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.
Neville DM; Scharff J; Srinivasachar K
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2585-9. PubMed ID: 1372981
[TBL] [Abstract][Full Text] [Related]
10. Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin.
Vallera DA; Taylor PA; Panoskaltsis-Mortari A; Blazar BR
Blood; 1995 Dec; 86(11):4367-75. PubMed ID: 7492798
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH
Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092
[TBL] [Abstract][Full Text] [Related]
12. Low-dose streptozocin-induced autoimmune diabetes in islet transplantation model.
Weide LG; Lacy PE
Diabetes; 1991 Sep; 40(9):1157-62. PubMed ID: 1834505
[TBL] [Abstract][Full Text] [Related]
13. Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes.
Hayward AR; Shreiber M
J Immunol; 1989 Sep; 143(5):1555-9. PubMed ID: 2527266
[TBL] [Abstract][Full Text] [Related]
14. Genetic control by I-A subregion in H-2 complex of incidence of streptozocin-induced autoimmune diabetes in mice.
Tanaka S; Nakajima S; Inoue S; Takamura Y; Aoki I; Okuda K
Diabetes; 1990 Oct; 39(10):1298-304. PubMed ID: 2145188
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
Herold KC; Vezys V; Sun Q; Viktora D; Seung E; Reiner S; Brown DR
J Immunol; 1996 May; 156(9):3521-7. PubMed ID: 8617981
[TBL] [Abstract][Full Text] [Related]
16. Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin.
Kobayashi T; Song QH; Hong T; Kitamura H; Cyong JC
Phytother Res; 2002 Jun; 16(4):377-82. PubMed ID: 12112297
[TBL] [Abstract][Full Text] [Related]
17. Examination of the immunosuppressive effect of delta9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes.
Li X; Kaminski NE; Fischer LJ
Int Immunopharmacol; 2001 Apr; 1(4):699-712. PubMed ID: 11357882
[TBL] [Abstract][Full Text] [Related]
18. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
Wang Z; Gleichmann H
Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
[TBL] [Abstract][Full Text] [Related]
19. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE).
Shehata AM; Quintanilla-Fend L; Bettio S; Singh CB; Ammon HP
Phytomedicine; 2011 Sep; 18(12):1037-44. PubMed ID: 21831620
[TBL] [Abstract][Full Text] [Related]
20. Effect of schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes.
El-Wakil HS; Aboushousha TS; El Haddad O; Gamil NB; Mansour T; El-Said H
J Egypt Soc Parasitol; 2002 Dec; 32(3):987-1002. PubMed ID: 12512830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
